ArticleMicrobiome2025
L. johnsonii alleviates methamphetamine craving via the metabolism of tyrosine.
Article in Microbiome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Research Progress on the Regulatory Mechanisms of Gut Microbiota in Methamphetamine Addiction and Targeted Interventions.Addiction biology · 2026Review
- Longitudinal dynamics of the gut microbiome during methamphetamine addiction and abstinence.Frontiers in microbiology · 2026Article
- Strain-resolved biology ofFrontiers in veterinary science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundMethamphetamine (MA) abuse is a global public problem and methamphetamine addiction lacks of effective treatment. The gut microbes, involved in the gut-brain axis, remotely regulate methamphetamine addiction.
resultsIn this study, we identified that Lactobacillus johnsonii (L. johnsonii) is involved in the metabolism of tyrosine. MA addiction disrupts the balance of gut microbes, reducing the abundance of L. johnsonii, destroying intestinal barrier integrity, and increasing the tyrosine level. The outbreak of tyrosine promotes a greater craving for MA in mice since it transfers from the intestine to VTA and NAc to promote microglia immune reactivity, which reduces energy supply to neurons and decreases presynaptic mitochondria in dopaminergic neurons. As a consequence, the dopaminergic presynaptic membrane reuptake process based on vesicular transport is affected, leading to maintain of dopamine in the synaptic cleft acting on the postsynaptic membrane with synaptic plasticity changes, resulting in MA craving. L. johnsonii transplantation rescues mice from MA craving by promoting the metabolism of tyrosine in intestine and improves the neuronal function in NAc and VTA.
conclusionsOur results reveal that MA addiction disrupts gut microbiota homeostasis and promotes tyrosine-mediated dopamine system dysfunction. L. johnsonii transplantation is recommended for the treatment of methamphetamine craving.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.